PTEN and neoplasm: Targeting this pathway at tumor suppressor (i.e., PTEN) and oncogene levels gives the advantage of not only attacking the pro-survival arm of the pathway but also ensuring apoptosis induction through restoration of its tumor suppressor function as well.